380 results on '"Chemoembolisation"'
Search Results
102. Die palliative Therapie des HCC.
103. Multiphase CT-Based Volumetric Analysis, Model for End-Stage Liver Disease (MELD score) and Outcomes of Trans-arterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma (HCC)
104. Extra-hepatic collateral supply to hepatocellular carcinoma: what a radiologist should know
105. Accessing the Liver: A Resident Educational Tool on Learning Y90 radioembolization and TACE Utilizing Detailed Clay Models with Guidewires
106. Radiation exposure dose for medical staff during Yttrium-90 radioembolization of hepatocellular carcinoma: what is the risk?
107. Activities of EURADOS Working Group 12 in establishing DRLs for Interventional Radiology, Cardiology & Cone Beam CT
108. The value of Dyna CT in the hepatocellular carcinoma treated by transcatheter arterial chemoembolisation : The experience of a tunisian center
109. Interventional radiological treatment of hepatocelular carcinoma: imaging review
110. The Hunter Experience with TACE: Correlation of Tumour Imaging Response (Based on EASL, mRECIST, and Novel Area Approximation Method) With Survival Following TACE in the Hunter New England Local Health District
111. Are cephalic radiation doses to interventional radiologists too high?
112. Transarterial chemoembolisation (TACE) of unrescectable or recurrent hepatic cholagiocarcinoma with or without thermal ablation: local tumour control and survival rates
113. Panorama of interventional oncology procedures in hepatobiliary and pancreatic malignancies
114. Long-term evaluation of transarterial chemoembolisation for hepatocellular carcinoma over 20 years: retrospective single center study
115. Carbon Dioxide Contrast Enhancement for C-Arm CT
116. Benefits of arterial enhancement fraction in the evaluation of the effect of transarterial chemoembolization
117. The role of radiology in hepatocellular carcinoma (HCC): from screening to hepatic transplantation
118. Chemoembolization of hepatic tumors in 20 patients: indications, technique and results
119. Is the arterial enhancement fraction (AEF) a suitable biomarker for the detection of residual or recurrent hepatic tumours after locoregional therapy?
120. Use of ethanol in the trans-arterial embolization (TAELE) in 1:1 mixture with lipiodol VS Conventional Trans-Arterial Chemo-Embolization (c-TACE )in stage HCC: Toxicity and survival study
121. Accuracy of CT in predicting failure of non-operative management of spleen traumatic injuries
122. Survival, Tumour Response and Safety 70-150μm versus 100-300μm Doxorubicin Drug-Eluting Beads in Trans-Arterial Chemoembolization for Hepatocellular Carcinoma
123. Splenic Embolization: Therapeutic alternative to splenectomy for primary immune thrombocytopenia
124. Selective ophthalmic artery chemotherapy as primary treatment in advanced stages of retinoblastoma : a prospective study
125. Quality of life indicators of liver-directed interventions for hepatic tumours - preliminary data
126. Comparison of the efficacy and safety of transarterial chemoembolization with and without Apatinib for the treatment of BCLC stage C hepatocellular carcinoma
127. Patients radiation dose and deterministic effects in patients with hepatocellular carcinoma (HCC) undergoing trans-arterial chemoembolization (TACE) procedures
128. TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib
129. MR elastography (MRE) and MRI as new response parameters of colorectal liver metastases (CRLM) using transarterial chemoembolisation (TACE)
130. Prognostic factors for survival in patients with hepatocellular carcinoma treated by transarterial chemoembolization using drug-eluting beads
131. The value of IVIM-DWI in the differential diagnosis of malignant hepatic nodules
132. Serie de casos de pacientes con hepatocarcinoma tratados con sorafenib como terapia puente a quimioembolización y finalmente como paliativo
133. Lokoregionale Therapieverfahren.
134. Interobserver variability in gross tumor volume delineation for hepatocellular carcinoma: Results of Korean Radiation Oncology Group 1207 study
135. Transcatheter arterial embolisation versus no treatment in cirrhotic patients with hepatocellular carcinoma: a retrospective comparative study.
136. 100. Adjuvante Therapie von Lebermetastasen.
137. Kombinationstherapie in der Onkologie – das hepatocelluläre Carcinom.
138. Occupational radiation exposure in chemoembolizations: Evaluation of doses in different body regions of professionals with different roles in the procedure
139. Transarterial chemoembolisation using small diameter drug eluting beads in patients with neuroendocrine liver metastases
140. Liver surface nodularity score as a new predictor of overall survival in patients with HCC treated by TACE
141. Transarterial Chemo-embolisation with degradable starch microspheres(DSM-TACE) in intermediate/advanced HCC patients dismissing or inelegible for Sorafenib
142. Imaging-guided therapy for hepatocellular carcinoma: techniques and post-therapeutic imaging aspects
143. Small Bowel Arteriovenous Malformation
144. Radiation exposure among different interventional radiology procedures
145. Endovascular treatment in HCC with an Extrahepatic Collateral artery
146. Transarterial chemoembolisation with lipiodol for unresectable hepatocellular carcinoma
147. Value of CT-scan based volumetric analysis on the prediction of outcomes of patients with hepatocellular carcinoma undergoing transarterial chemoembolization (TACE)
148. Focal and diffuse hyperintense hepatic lesions on unenhanced T1-weighted MR images: a pictorial essay
149. Interesting case of bilateral paragangliomas neck in a 34 years old female
150. Imaging features of hepatic malignancies during and after interventional radiological procedures: a practical guide for radiologists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.